BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leppik L, Parksepp M, Janno S, Koido K, Haring L, Vasar E, Zilmer M. Profiling of lipidomics before and after antipsychotic treatment in first-episode psychosis. Eur Arch Psychiatry Clin Neurosci 2020;270:59-70. [PMID: 30604052 DOI: 10.1007/s00406-018-0971-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Tkachev A, Stekolshchikova E, Vanyushkina A, Zhang H, Morozova A, Zozulya S, Kurochkin I, Anikanov N, Egorova A, Yushina E, Vogl T, Senner F, Schaupp SK, Reich-Erkelenz D, Papiol S, Kohshour MO, Klöhn-Saghatolislam F, Kalman JL, Heilbronner U, Heilbronner M, Gade K, Comes AL, Budde M, Anderson-Schmidt H, Adorjan K, Wiltfang J, Reininghaus EZ, Juckel G, Dannlowski U, Fallgatter A, Spitzer C, Schmauß M, von Hagen M, Zorkina Y, Reznik A, Barkhatova A, Lisov R, Mokrov N, Panov M, Zubkov D, Petrova D, Zhou C, Liu Y, Pu J, Falkai P, Kostyuk G, Klyushnik T, Schulze TG, Xie P, Schulte EC, Khaitovich P. Lipid Alteration Signature in the Blood Plasma of Individuals With Schizophrenia, Depression, and Bipolar Disorder. JAMA Psychiatry 2023. [PMID: 36696101 DOI: 10.1001/jamapsychiatry.2022.4350] [Reference Citation Analysis]
2 Song M, Liu Y, Zhou J, Shi H, Su X, Shao M, Yang Y, Wang X, Zhao J, Guo D, Liu Q, Zhang L, Zhang Y, Lv L, Li W. Potential plasma biomarker panels identification for the diagnosis of first-episode schizophrenia and monitoring antipsychotic monotherapy with the use of metabolomics analyses. Psychiatry Res 2023;321:115070. [PMID: 36706560 DOI: 10.1016/j.psychres.2023.115070] [Reference Citation Analysis]
3 Su L, Xiu M, Guan X, Wu F. Lysophosphatidylethanolamine correlated with cognitive improvements after treatment with olanzapine in drug-naïve first-episode schizophrenia: a prospective cohort study.. [DOI: 10.21203/rs.3.rs-2339101/v1] [Reference Citation Analysis]
4 Edenhofer F, Spathopoulou A, Fenkart G, Marteau V, Podlesnic M, Kruszewski K, Koskuvi M, Réthelyi J, Apáti Á, Conti L, Ku M, Koal T, Müller U, Talmazan R, Ojansuu I, Vaurio O, Lähteenvuo M, Lehtonen Š, Mertens J, Günther K, Tiihonen J, Koistinaho J, Trajanoski Z. Integrative metabolomics-genomics analysis identifies key networks in a stem cell-based model of schizophrenia.. [DOI: 10.21203/rs.3.rs-2175912/v1] [Reference Citation Analysis]
5 Jaago M, Rähni A, Pupina N, Pihlak A, Sadam H, Tuvikene J, Avarlaid A, Planken A, Planken M, Haring L, Vasar E, Baćević M, Lambert F, Kalso E, Pussinen P, Tienari PJ, Vaheri A, Lindholm D, Timmusk T, Ghaemmaghami AM, Palm K. Differential patterns of cross-reactive antibody response against SARS-CoV-2 spike protein detected for chronically ill and healthy COVID-19 naïve individuals. Sci Rep 2022;12:16817. [PMID: 36207326 DOI: 10.1038/s41598-022-20849-6] [Reference Citation Analysis]
6 Mednova IA, Chernonosov AA, Kornetova EG, Semke AV, Bokhan NA, Koval VV, Ivanova SA. Levels of Acylcarnitines and Branched-Chain Amino Acids in Antipsychotic-Treated Patients with Paranoid Schizophrenia with Metabolic Syndrome. Metabolites 2022;12:850. [PMID: 36144254 DOI: 10.3390/metabo12090850] [Reference Citation Analysis]
7 Wang X, Xiu M, Wang K, Su X, Li X, Wu F. Plasma linoelaidyl carnitine levels positively correlated with symptom improvement in olanzapine-treated first-episode drug-naïve schizophrenia. Metabolomics 2022;18:50. [PMID: 35819637 DOI: 10.1007/s11306-022-01909-4] [Reference Citation Analysis]
8 Couttas TA, Jieu B, Rohleder C, Leweke FM. Current State of Fluid Lipid Biomarkers for Personalized Diagnostics and Therapeutics in Schizophrenia Spectrum Disorders and Related Psychoses: A Narrative Review. Front Psychiatry 2022;13:885904. [PMID: 35711577 DOI: 10.3389/fpsyt.2022.885904] [Reference Citation Analysis]
9 Parksepp M, Haring L, Kilk K, Koch K, Uppin K, Kangro R, Zilmer M, Vasar E. The Expanded Endocannabinoid System Contributes to Metabolic and Body Mass Shifts in First-Episode Schizophrenia: A 5-Year Follow-Up Study. Biomedicines 2022;10:243. [PMID: 35203453 DOI: 10.3390/biomedicines10020243] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Tkachev AI, Stekolshchikova EA, Morozova AY, Anikanov NA, Zorkina YA, Alekseyeva PN, Khobta EB, Andreyuk DS, Zozulya SA, Barkhatova AN, Klyushnik TP, Reznik AM, Kostyuk GP, Khaitovich PE. Ceramides: Shared Lipid Biomarkers of Cardiovascular Disease and Schizophrenia. Consortium Psychiatricum 2021;2:35-43. [DOI: 10.17816/cp101] [Reference Citation Analysis]
11 Liu J, Xiu M, Liu H, Wang J, Li X. Plasma Lysophosphatidylcholine and Lysophosphatidylethanolamine Levels Were Associated With the Therapeutic Response to Olanzapine in Female Antipsychotics-naïve First-episode Patients With Schizophrenia. Front Pharmacol 2021;12:735196. [PMID: 34603051 DOI: 10.3389/fphar.2021.735196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Zhang Q, He H, Bai X, Jiang L, Chen W, Zeng X, Li Y, Teixeira AL, Dai J. Unveiling the Metabolic Profile of First-Episode Drug-Naïve Schizophrenia Patients: Baseline Characteristics of a Longitudinal Study Among Han Chinese. Front Psychiatry 2021;12:702720. [PMID: 34305687 DOI: 10.3389/fpsyt.2021.702720] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Tkachev A, Stekolshchikova E, Anikanov N, Zozulya S, Barkhatova A, Klyushnik T, Petrova D. Shorter Chain Triglycerides Are Negatively Associated with Symptom Improvement in Schizophrenia. Biomolecules 2021;11:720. [PMID: 34064997 DOI: 10.3390/biom11050720] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Canfrán-Duque A, Pastor Ó, García-Seisdedos D, Molina YL, Babiy B, Lerma M, Sánchez-Castellano C, Martínez-Botas J, Gómez-Coronado D, Lasunción MA, Cruz-Jentoft AJ, Busto R. The Antipsychotic Risperidone Alters Dihydroceramide and Ceramide Composition and Plasma Membrane Function in Leukocytes In Vitro and In Vivo. Int J Mol Sci 2021;22:3919. [PMID: 33920193 DOI: 10.3390/ijms22083919] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ermakov EA, Dmitrieva EM, Parshukova DA, Kazantseva DV, Vasilieva AR, Smirnova LP. Oxidative Stress-Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives. Oxid Med Cell Longev 2021;2021:8881770. [PMID: 33552387 DOI: 10.1155/2021/8881770] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 14.0] [Reference Citation Analysis]
16 Klupczynska A, Plewa S, Dereziński P, Garrett TJ, Rubio VY, Kokot ZJ, Matysiak J. Identification and quantification of honeybee venom constituents by multiplatform metabolomics. Sci Rep 2020;10:21645. [PMID: 33303913 DOI: 10.1038/s41598-020-78740-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Seabra G, de Almeida V, Reis-de-Oliveira G, Crunfli F, Antunes ASLM, Martins-de-Souza D. Ubiquitin-proteasome system, lipid metabolism and DNA damage repair are triggered by antipsychotic medication in human oligodendrocytes: implications in schizophrenia. Sci Rep 2020;10:12655. [PMID: 32724114 DOI: 10.1038/s41598-020-69543-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
18 Wang D, Sun X, Maziade M, Mao W, Zhang C, Wang J, Cao B. Characterising phospholipids and free fatty acids in patients with schizophrenia: A case-control study. World J Biol Psychiatry 2021;22:161-74. [PMID: 32677491 DOI: 10.1080/15622975.2020.1769188] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Piirsalu M, Taalberg E, Lilleväli K, Tian L, Zilmer M, Vasar E. Treatment With Lipopolysaccharide Induces Distinct Changes in Metabolite Profile and Body Weight in 129Sv and Bl6 Mouse Strains. Front Pharmacol 2020;11:371. [PMID: 32292347 DOI: 10.3389/fphar.2020.00371] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
20 de Almeida V, Alexandrino GL, Aquino A, Gomes AF, Murgu M, Guest PC, Steiner J, Martins-de-souza D. Changes in the blood plasma lipidome associated with response to atypical antipsychotic treatments in schizophrenia.. [DOI: 10.1101/2020.03.25.008474] [Reference Citation Analysis]